78 results on '"Douglass, Harold O."'
Search Results
2. Multimodality Therapy for Completely Resected (R0) Gastric Cancer (Excluding Japanese Trials)
3. Adjuvant Therapy of Gastric Cancer in the West
4. Rationale for the intraperitoneal approach to surgical adjuvant chemotherapy of gastric cancer
5. At least, do no harm
6. Problems in Surgical Oncology: The Surgical Approach to Recurrent and Metastatic Cancer
7. End results of radiation therapy, alone and combination with 5-fluorouracil in colorectal cancers
8. Gastric Cancer: D2 Dissection or Low Maruyama Index-Based Surgery—a Debate
9. Detection and treatment of the micrometastases of gastric cancer
10. Should Adjuvant Therapy Remain the Standard of Care for Patients With Resected Adenocarcinoma of the Pancreas?
11. Gastric Cancer: D2 All Over Again
12. Predictive factors associated with long-term survival in patients with neuroendocrine tumors of the pancreas
13. Effect of Concurrent Radiation Therapy and Chemotherapy on Pulmonary Function in Patients with Esophageal Cancer
14. High-grade dysplasia within Barrett's esophagus: Controversies regarding clinical opinions and approaches
15. Perihilar cancer
16. Esophageal resection for carcinoma in patients older than 70 years
17. Is Glucagonoma of the Pancreas a Curable Disease?
18. Management of Cystic Neoplasms of the Pancreas
19. Preliminary clinical data on a new photodynamic therapy photosensitizer: 2-[1-hexyloxyethyl]-2-devinylpyropheophorbide-a (HPPH) for treatment of obstructive esophageal cancer
20. Outcome of Patients With Proximal Gastric Cancer Depends on Extent of Resection and Number of Resected Lymph Nodes
21. Combined chemoradiotherapy vs. radiotherapy alone for early stage squamous cell carcinoma of the esophagus: a study of the eastern cooperative oncology group
22. Investigation of disease-free survival as a surrogate endpoint for survival in cancer clinical trials
23. Carcinoma of the Gallbladder
24. D2 dissection for gastric cancer
25. A Phase II Study of 5-Fluorouracil, Leucovorin, Adriamycin, and Cisplatin (FLAP) for Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma
26. Survival benefit of extended D2 resection for proximal gastric cancer
27. Phase II Study of ZD1694 in Patients With Advanced Gastric Cancer
28. Granulocyte-macrophage colony-stimulating factor as infection prophylaxis in high-risk oncologic surgery
29. Local resection of early gastric carcinoma
30. Phase II trial of ZD1694 (TomudexTM) in patients with advanced pancreatic cancer
31. Phase II Trial of Etoposide, Doxorubicin, and Cisplatin Combination in Advanced Measurable Gastric Cancer
32. Adjuvant therapy for pancreatic cancer
33. Evaluating the role of photodynamic therapy in the management of pancreatic cancer
34. Age and sex are independent predictors of 5-fluorouracil toxicity. Analysis of a large scale phase III trial
35. Adenocarcinoma of the small intestine: 21-Year review of diagnosis, treatment, and prognosis
36. R2 Dissection in the Treatment of Gastric Malignancy
37. Neutropenic enterocolitis. Clinical diagnosis and treatment
38. Unusual Gastrointestinal Complications of Interleukin-2 Therapy
39. Pancreatic cancer why patients die
40. A phase II trial of 5-fluorouracil, doxorubicin, mitomycin C, and leucovorin in advanced gastric carcinoma
41. Plasma selenium levels in patients with advanced upper gastrointestinal cancer
42. Staging laparotomy with splenectomy in children and adolescents with Hodgkin's disease
43. Comparison of intramural 5-fluorouracil and more conventional routes of drug administration on concentrations in gastric regional lymph nodes: A potential for trans-endoscopic adjuvant chemotherapy
44. Evaluation of a human pancreas-specific antigen by enzyme-linked immunosorbent assay
45. Tumor antigens as related to pancreatic cancer
46. Gastrointestinal carcinoids: Extrahepatic metastases and symptomatology following resection
47. Rhabdomyosarcoma of the duodenum with sinus tract formation into the gastric wall, visualized by gastroduodenoscopy
48. Combination chemotherapy of advanced colorectal cancer utilizing 5-fluorouracil, semustine, dacarbazine, vincristine, and hydroxyurea: A phase III trial by the eastern cooperative oncology group (EST: 4275)
49. Prognostic effect of weight loss prior tochemotherapy in cancer patients
50. Combination chemotherapy containing semustine (MeCCNU) in patients with advanced colorectal cancer previously treated with 5-fluorouracil (5-Fu)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.